Katherine M Johnson1, Michele R Hacker1, Nina Resetkova2, Barbara O'Brien1, Anna M Modest3. 1. Department of Obstetrics and Gynecology, Beth Israel Deaconess Medical Center, Boston; Department of Obstetrics, Gynecology, and Reproductive Biology, Harvard Medical School, Boston. 2. Department of Obstetrics and Gynecology, Beth Israel Deaconess Medical Center, Boston; Department of Obstetrics, Gynecology, and Reproductive Biology, Harvard Medical School, Boston; Boston IVF, Waltham, Massachusetts. 3. Department of Obstetrics and Gynecology, Beth Israel Deaconess Medical Center, Boston; Department of Obstetrics, Gynecology, and Reproductive Biology, Harvard Medical School, Boston. Electronic address: ammodest@bidmc.harvard.edu.
Abstract
OBJECTIVES: To evaluate the association of fresh and frozen embryo transfer with the development of ischemic placental disease (IPD), hypothesizing that differences in implantation environment affect placentation and thus pregnancy outcomes. DESIGN: We performed a secondary analysis of a retrospective cohort study of deliveries linked to IVF cycles. SETTING: Tertiary hospital and infertility treatment center. PATIENT(S): We included all women who underwent an autologous IVF cycle and had a live-born infant or an intrauterine fetal demise (IUFD). We excluded women less than 18 years of age. INTERVENTION(S): We compared pregnancies resulting from frozen embryo transfer (frozen) cycles with those resulting from fresh embryo transfer (fresh) cycles. MAIN OUTCOME MEASURE(S): The primary outcome was a composite outcome of IPD or IUFD due to placental insufficiency. Ischemic placental disease included pre-eclampsia, placental abruption, and small for gestational age (SGA). We calculated risk ratios (RRs) and 95% confidence intervals (CIs). RESULT(S): Compared with fresh cycles, frozen cycles had a lower risk of IPD or IUFD from placental insufficiency (RR 0.75, 95% CI 0.59-0.97). Frozen cycles also conferred a lower risk of SGA than fresh cycles (RR 0.58, 95% CI 0.41-0.81). Risks of pre-eclampsia (RR 1.3, 95% CI 0.84-1.9) and abruption (RR 1.2, 95% CI 0.56-2.4) were similar. CONCLUSION(S): There was a lower risk of IPD among frozen cycles compared with fresh cycles. This association was largely driven by lower risk of SGA among frozen cycles.
OBJECTIVES: To evaluate the association of fresh and frozen embryo transfer with the development of ischemic placental disease (IPD), hypothesizing that differences in implantation environment affect placentation and thus pregnancy outcomes. DESIGN: We performed a secondary analysis of a retrospective cohort study of deliveries linked to IVF cycles. SETTING: Tertiary hospital and infertility treatment center. PATIENT(S): We included all women who underwent an autologous IVF cycle and had a live-born infant or an intrauterine fetal demise (IUFD). We excluded women less than 18 years of age. INTERVENTION(S): We compared pregnancies resulting from frozen embryo transfer (frozen) cycles with those resulting from fresh embryo transfer (fresh) cycles. MAIN OUTCOME MEASURE(S): The primary outcome was a composite outcome of IPD or IUFD due to placental insufficiency. Ischemic placental disease included pre-eclampsia, placental abruption, and small for gestational age (SGA). We calculated risk ratios (RRs) and 95% confidence intervals (CIs). RESULT(S): Compared with fresh cycles, frozen cycles had a lower risk of IPD or IUFD from placental insufficiency (RR 0.75, 95% CI 0.59-0.97). Frozen cycles also conferred a lower risk of SGA than fresh cycles (RR 0.58, 95% CI 0.41-0.81). Risks of pre-eclampsia (RR 1.3, 95% CI 0.84-1.9) and abruption (RR 1.2, 95% CI 0.56-2.4) were similar. CONCLUSION(S): There was a lower risk of IPD among frozen cycles compared with fresh cycles. This association was largely driven by lower risk of SGA among frozen cycles.
Authors: Judy E Stern; Chia-Ling Liu; Howard J Cabral; Elliott G Richards; Charles C Coddington; Stacey A Missmer; Hafsatou Diop Journal: Fertil Steril Date: 2018-08 Impact factor: 7.329
Authors: S Opdahl; A A Henningsen; A Tiitinen; C Bergh; A Pinborg; P R Romundstad; U B Wennerholm; M Gissler; R Skjærven; L B Romundstad Journal: Hum Reprod Date: 2015-04-29 Impact factor: 6.918
Authors: Anthony N Imudia; Awoniyi O Awonuga; Joseph O Doyle; Anjali J Kaimal; Diane L Wright; Thomas L Toth; Aaron K Styer Journal: Fertil Steril Date: 2012-04-10 Impact factor: 7.329
Authors: Liv Bente Romundstad; Pål R Romundstad; Arne Sunde; Vidar von Düring; Rolv Skjaerven; David Gunnell; Lars J Vatten Journal: Lancet Date: 2008-07-30 Impact factor: 79.321
Authors: Anna M Modest; Louisa H Smith; Thomas L Toth; Ai-Ris Y Collier; Michele R Hacker Journal: Paediatr Perinat Epidemiol Date: 2022-01-04 Impact factor: 3.980
Authors: Marjan Van Reckem; Christophe Blockeel; Maryse Bonduelle; Andrea Buysse; Mathieu Roelants; Greta Verheyen; Herman Tournaye; Frederik Hes; Florence Belva Journal: Hum Reprod Open Date: 2021-02-19